John F. Timms

8.8k citations

103 papers · 6.7k indexed · 2 hit papers · h-index 40

Impact in

Molecular Biology top 1%
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Metabolomics and Mass Spectrometry Studies
- Protein Tyrosine Phosphatases
- Glycosylation and Glycoproteins Research
Cancer Research top 2%

Papers in

Spectroscopy 32
- Advanced Proteomics Techniques and Applications 29
- Mass Spectrometry Techniques and Applications 18
Reproductive Medicine 10
- Ovarian cancer diagnosis and treatment 8

Co-authors: Michael D. Waterfield Khatereh Ahmadi Roy Katso Rainer Cramer S. L. White Klaus Okkenhaug Sally J. Leevers Peter J. Parker
Journals: PROTEOMICS (8 papers)British Journal of Cancer (6 papers)Cancer Research (4 papers)Journal of Proteomics (4 papers)PROTEOMICS - CLINICAL APPLICATIONS (4 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

John F. Timms

103 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

Synthesis and Function of 3-Phosphorylated Inositol Lipids 2001 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Annual Review of Biochemistry
2001 Annual Review of Cell and Developmental Biology

Peers

Countries citing papers authored by John F. Timms

Since Specialization

Citations

This map shows the geographic impact of John F. Timms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Timms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Timms more than expected).

Fields of papers citing papers by John F. Timms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Timms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Timms. The network helps show where John F. Timms may publish in the future.

Co-authors

The 25 scholars most cited alongside John F. Timms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John F. Timms Line = papers co-authored together John F. Timms links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes EBioMedicine ·Lucy Oldfield, A.G. Evans, De Luyck, Claire Jenkinson, Tejpal Purewal, Eftychia Eirini Psarelli, Usha Menon, John F. Timms, Stephen P. Pereira, Paula Ghaneh, William Greenhalf, Christopher Halloran, Eithne Costello	2022	23
2	Non-Histone Protein Methylation: Biological Significance and Bioengineering Potential ACS Chemical Biology ·Andriy Zubarev, Oleg Blyuss, John F. Timms, Daniel Conole, Francesca Ceroni, Harry J. Whitwell	2021	36
3	Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties Cancer Research ·Lawrence N. Barrera, A.G. Evans, Brian R. Lane, 禎子渡辺, LI Yaqu, Fiona Campbell, Timothy Andrews, Zipeng Lu, Pedro A. Pérez–Mancera, Triantafillos Liloglou, Milton Ashworth, Vincentia Tri H, Nataliia M. Yeftieni, Quentin Nunes, Phoebe A. Phillips, John F. Timms, Christopher Halloran, William Greenhalf, John P. Neoptolemos, Eithne Costello	2020	25
4	Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women Cancers ·Aleksandra Gentry‐Maharaj, Oleg Blyuss, Andy Ryan, Matthew Burnell, Chloe Karpinskyj, Richard Gunu, Jatinderpal Kalsi, Anne Dawnay, Inés P. Mariño, Ranjit Manchanda, Karen H. Lu, Wei-Lei Yang, John F. Timms, Max Parmar, Steven J. Skates, Robert C. Bast, Ian Jacobs, Alexey Zaikin, Usha Menon	2020	22
5	Improved early detection of ovarian cancer using longitudinal multimarker models British Journal of Cancer ·Harry J. Whitwell, Jenny Worthington, Oleg Blyuss, Aleksandra Gentry‐Maharaj, Andy Ryan, Richard Gunu, Jatinderpal Kalsi, Usha Menon, Ian Jacobs, Alexey Zaikin, John F. Timms	2020	69
6	Discovery of non-invasive biomarkers for the diagnosis of endometriosis Clinical Proteomics ·Tuukka Rouhiainen, D. Mavrelos, Jenny Worthington, Oleg Blyuss, Ertan Sarıdoğan, John F. Timms	2019	39
7	Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population Clinical Cancer Research ·Oleg Blyuss, Matthew Burnell, Andy Ryan, Aleksandra Gentry‐Maharaj, Inés P. Mariño, Jatinderpal Kalsi, Ranjit Manchanda, John F. Timms, Mahesh Parmar, Steven J. Skates, Ian Jacobs, Alexey Zaikin, Usha Menon	2018	39
8	Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis International Journal of Molecular Sciences ·Shibu Krishnan, Harry J. Whitwell, Gunnar Lenz, Aleksandra Gentry‐Maharaj, Usha Menon, Stephen P. Pereira, Marco Gaspari, John F. Timms	2017	23
9	The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing Biochemical Pharmacology ·F. Arnoult, Anna N. Melidoni, Diana Hernandez, Bilal Omar, B Wiederauftreten Der Problematik, Camila Aparecida Heinen, Flora Scott, Dorsa Varshavi, Jeremy R. Everett, Yugo Tsuchiya, John F. Timms, Ian Phillips, Elizabeth A. Shephard	2015	39
10	Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection Clinical Cancer Research ·Darragh P. O’Brien, Neomal S. Sandanayake, Claire Jenkinson, Aleksandra Gentry‐Maharaj, Sophia Apostolidou, Evangelia‐Ourania Fourkala, Stéphane Camuzeaux, Oleg Blyuss, Richard Gunu, Anne Dawnay, Alexey Zaikin, Ross C. Smith, Ian Jacobs, Usha Menon, Eithne Costello, Stephen P. Pereira, John F. Timms	2014	147
11	Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer Journal of Proteomics ·C Jenkinson, Victoria A. Elliott, Usha Menon, Sophia Apostolidou, Hau-Yung Chen, Aleksandra Gentry‐Maharaj, Stephen P. Pereira, Ian Jacobs, Trevor F. Cox, William Greenhalf, John F. Timms, Robert Sutton, John P. Neoptolemos, Eithne Costello	2014	34
12	AGR2 Is a Novel Surface Antigen That Promotes the Dissemination of Pancreatic Cancer Cells through Regulation of Cathepsins B and D Cancer Research ·Laurent Dumartin, Hannah J. Whiteman, Mark C. Willingham, Deepak Hariharan, Branko Dmitrović, Christine A. Iacobuzio–Donahue, Teresa A. Brentnall, Mary P. Bronner, Roger Feakins, John F. Timms, Caroline H. Brennan, Nicholas R. Lemoine, Tatjana Crnogorac‐Jurcevic	2011	118
13	Identification of Aldo-Keto Reductase AKR1B10 as a Selective Target for Modification and Inhibition by Prostaglandin A1: Implications for Antitumoral Activity Cancer Research ·Beatriz Díez-Dacal, Javier Machín Gayarre, Severine Gharbi, John F. Timms, Claire Coderch, Federico Gago, Dolores Pérez‐Sala	2011	42
14	LC-MS/MS in Proteomics Methods in molecular biology ·Pedro R. Cutillas, John F. Timms, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2010	5
15	LC-MS/MS in proteomics : methods and applications Humana Press eBooks ·Pedro R. Cutillas, John F. Timms	2010	6
16	Book Review: Cancer Proteomics from Bench to Bedside (edited by Sayed S. Daoud, Humana Press, ISBN 978-1-58829-858-4) UCL Discovery (University College London) ·John F. Timms	2008	1
17	The Role of S100P in the Invasion of Pancreatic Cancer Cells Is Mediated through Cytoskeletal Changes and Regulation of Cathepsin D Cancer Research ·Hannah J. Whiteman, Mark C. Willingham, Sally E. Dowen, Sayka Barry, John F. Timms, Nicholas R. Lemoine, Tatjana Crnogorac‐Jurcevic	2007	85
18	Endothelial ultrastructure in human endometrium following exposure to levonorgestrel intrauterine system Journal of Anatomy ·Harlow J. Hudgson, Ezequiel Yanchina Ubaldini, John F. Timms, 渡白木, IT Cameron, Prasanth Sudheendaran, Dr. M.D. Shende, Tin Chiu Li, Peter Dockery	2002	1
19	Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells Oncogene ·John F. Timms, S. L. White, Michael J. O’Hare, Michael D. Waterfield	2002	56
20	Computer control of anticoagulant dose BMJ ·Allison James, Jennifer Kadala, John F. Timms, R P Britt	1989	13

About John F. Timms

John F. Timms is a scholar working on Spectroscopy, Reproductive Medicine, Molecular Biology, Oncology and Cancer Research, having authored 103 papers that have together received 6.7k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (29 papers), Mass Spectrometry Techniques and Applications (18 papers), Metabolomics and Mass Spectrometry Studies (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Glycosylation and Glycoproteins Research (9 papers), Ovarian cancer diagnosis and treatment (8 papers), Cellular Mechanics and Interactions (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Molecular Biology (4.2k citations), Cancer Research (787 citations), Immunology (1.1k citations), Cell Biology (816 citations) and Spectroscopy (724 citations). John F. Timms has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Michael D. Waterfield, Khatereh Ahmadi, Roy Katso, Rainer Cramer, S. L. White, Klaus Okkenhaug, Sally J. Leevers, Peter J. Parker, Bart Vanhaesebroeck and Paul C. Driscoll. Their work appears in journals such as PROTEOMICS, British Journal of Cancer, Cancer Research, Journal of Proteomics and PROTEOMICS - CLINICAL APPLICATIONS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact